Use Cases
Skin & Hair
Skin, Hair and Wound Healing
The KLOW and GLOW stacks are the most-discussed cosmetic peptide combinations. Here is what each ingredient actually has behind it.
DPreclinical ResearchReviewed September 1, 2026
Compounds used for this goal
The reason
Why people use it
- GHK-Cu is the anchor of both blends and has the longest cosmetic history, appearing in topical skincare for decades on the basis of collagen and wound-healing research.
- KLOW adds KPV, an anti-inflammatory tripeptide fragment studied in inflammatory bowel and skin models, which is why the blend is discussed for inflammatory skin conditions rather than ageing alone.
- BPC-157 and TB-500 are included for tissue repair, and hair interest follows from the copper-peptide and follicle-signalling literature rather than from any hair-specific trial.
The evidence
What the research shows
- GHK-Cu has genuine laboratory and animal evidence for collagen synthesis, antioxidant activity and wound closure, and reasonable human evidence as a topical cosmetic ingredient.
- KPV has animal and in-vitro anti-inflammatory data, largely in colitis and dermatitis models. Human trials are essentially absent.
- TB-500 is a synthetic fragment of thymosin beta-4; the parent molecule reached human trials for wound and eye indications, but the fragment's evidence for the parent should not be read as evidence for the fragment.
- Neither KLOW nor GLOW as a combination has been tested in any published study. Blends are not studied as blends — every claim about them is assembled from single-ingredient research.
Reported use
How it is reported to be used
- Both blends are almost always discussed as subcutaneous injections in community reporting, despite GHK-Cu's evidence being predominantly topical — an important mismatch between the research and the practice.
- Reported timelines run in weeks to months for skin texture and considerably longer for hair, consistent with normal follicle cycles rather than with any measured effect.
- Injection-site irritation and transient flushing are the most frequently reported complaints, and injection-site infection is a documented risk with non-sterile technique.
Our reading
Evidence verdict
DPreclinical ResearchAnimal and laboratory research only. No meaningful published human data.
Preclinical. Real laboratory and animal signals for individual ingredients, no human trial of either blend, and a route of administration that does not match the strongest ingredient evidence.
Before you read further
Cautions and open questions
- Copper peptides carry a theoretical copper-accumulation concern with sustained high exposure; no human dosing safety data exist for injected use.
- Multi-ingredient vials make adverse reactions impossible to attribute to a single component.
- Compounds sold as research use only are not approved drugs, and identity and sterility are not established by the label.
Sources
Referenced research
- Narrative review2015
GHK peptide as a natural modulator of tissue remodelling
BioMed Research International- Main finding
- Summarises collagen, antioxidant and wound-repair findings, largely from laboratory and animal models.
- Animal study
KPV tripeptide anti-inflammatory activity in animal models
Educational content only. This page is not medical advice, a protocol or an individualised dosing recommendation. Reported use patterns summarise published literature and community reporting; they are not verified clinical cases and are not endorsements. Speak to a qualified healthcare professional about your own health.
All use cases